What is the treatment for Synthetic Cannabinoid (Spice) intoxication?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The treatment for Synthetic Cannabinoid (Spice) intoxication primarily involves supportive care, with a focus on managing symptoms and preventing complications, as there is no specific antidote available. When managing Synthetic Cannabinoid intoxication, it's crucial to consider the potential for severe symptoms, including psychosis, seizures, and cardiovascular issues. The approach to treatment should be multifaceted:

  • Symptomatic treatment: This may include the use of benzodiazepines for agitation or seizures, as well as anti-emetics for nausea and vomiting, similar to the management of Cannabinoid Hyperemesis Syndrome (CHS) as described by 1.
  • Cardiovascular support: Monitoring and management of cardiovascular complications, such as hypertension or tachycardia, are essential.
  • Psychological support: Patients may require psychiatric evaluation and treatment for any underlying mental health conditions that may be exacerbated by Synthetic Cannabinoid use. Key considerations in the management of Synthetic Cannabinoid intoxication include:
  • Avoidance of opioids due to the risk of worsening nausea and potential for addiction, as noted in the context of CHS management 1.
  • The potential role of topical capsaicin, haloperidol, promethazine, olanzapine, and ondansetron in acute and short-term care, although these are more specifically studied in the context of CHS 1. Given the lack of specific evidence on Synthetic Cannabinoid intoxication treatment, a cautious approach, prioritizing supportive care and symptom management, is recommended, drawing from principles of managing related conditions like CHS, as outlined in recent clinical updates 1.

From the Research

Treatment for Synthetic Cannabinoid (Spice) Intoxication

  • The treatment for Synthetic Cannabinoid (Spice) intoxication is primarily focused on managing the symptoms and supporting the patient's vital functions 2.
  • Non-pharmacological interventions such as ventilatory support and restraints may be used to manage agitation and aggression, which are common presentations of Spice intoxication 2.
  • Pharmacological agents such as benzodiazepines and antipsychotics may be prescribed to manage symptoms such as anxiety, agitation, and psychosis 2.
  • De-escalation strategies, including verbal de-escalation, are recommended as the initial approach to manage agitation and aggression, but their use is not well reported in studies 2.
  • The treatment of Synthetic Cannabinoid (Spice) intoxication may involve managing symptoms such as tachycardia, nausea, somnolence, hypokalemia, hypertension, restlessness, and/or agitation, which are commonly reported in patients who have used JWH-210, a type of Synthetic Cannabinoid 3.
  • Cardiovascular effects, including alterations in blood pressure and heart rate, as well as changes in the electrocardiogram (ECG), may also need to be managed in patients with Synthetic Cannabinoid (Spice) intoxication 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Guidelines and treatment for illicit drug related presentations in emergency departments: A scoping review.

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.